10-Q Filing

NEUROCRINE BIOSCIENCES INC CIK: 914475 Q2 2019

Filing Information

Form Type	10-Q
Accession Number	`0001564590-19-026602`
Period End Date	20190630
Filing Date	20190729
Fiscal Year	2019
Fiscal Period	Q2
XBRL Instance	nbix-10q_20190630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 71 Income Statement 76 Cash Flow Statement 57 Stockholders Equity 31

Balance Sheet 71 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$141.71M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$140.99M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments in available-for-sale debt securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$478.99M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments in available-for-sale debt securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$509.20M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$95.36M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$56.24M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	220.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	220.00M	shares	Point-in-time
Inventory	`InventoryNet`	$12.02M	USD	Point-in-time
Inventory	`InventoryNet`	$10.86M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$19.76M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	91.54M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	90.80M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$21.45M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	91.54M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	90.80M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$737.78M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$748.81M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$5.48M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$5.48M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$33.87M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$39.62M	USD	Point-in-time
Long-term investments in available-for-sale debt securities	`AvailableForSaleSecuritiesNoncurrent`	$146.50M	USD	Point-in-time
Long-term investments in available-for-sale debt securities	`AvailableForSaleSecuritiesNoncurrent`	$216.03M	USD	Point-in-time
Investment in restricted equity securities	`EquitySecuritiesFvNiRestricted`	$77.36M	USD	Point-in-time
Operating lease assets	`OperatingLeaseRightOfUseAsset`	$49.09M	USD	Point-in-time
Total assets	`Assets`	$993.15M	USD	Point-in-time
Total assets	`Assets`	$1.07B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$95.03M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$86.38M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$5.56M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.86M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$88.23M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$100.59M	USD	Point-in-time
Noncurrent operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$66.19M	USD	Point-in-time
Convertible senior notes	`ConvertibleDebtNoncurrent`	$388.50M	USD	Point-in-time
Convertible senior notes	`ConvertibleDebtNoncurrent`	$398.47M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$10.23M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$17.91M	USD	Point-in-time
Deferred rent	`DeferredRentCreditNoncurrent`	$18.11M	USD	Point-in-time
Deferred gain on sale of real estate	`DeferredGainOnSaleOfRealEstateNoncurrent`	$7.31M	USD	Point-in-time
Total liabilities	`Liabilities`	$583.15M	USD	Point-in-time
Total liabilities	`Liabilities`	$512.39M	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 220,000 shares authorized; issued and outstanding shares were 91,536 as of June 30, 2019 and 90,797 as of December 31, 2018	`CommonStockValue`	$92.00K	USD	Point-in-time
Common stock, $0.001 par value; 220,000 shares authorized; issued and outstanding shares were 91,536 as of June 30, 2019 and 90,797 as of December 31, 2018	`CommonStockValue`	$91.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.66B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.70B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$645.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.93M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.18B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.22B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$409.27M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$372.14M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$364.49M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$483.71M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$480.76M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$377.44M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.07B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$993.15M	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$183.58M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$321.98M	USD	2 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$167.99M	USD	2 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$96.91M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$1.61M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$1.80M	USD	2 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$854.00K	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$2.74M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$61.69M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$36.99M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$85.94M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$99.34M	USD	2 Qtrs
Acquired in-process research and development	`ResearchAndDevelopmentInProcess`	$118.08M	USD	2 Qtrs
Acquired in-process research and development	`ResearchAndDevelopmentInProcess`	$5.00M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$80.82M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$60.91M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$119.55M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$168.36M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$98.76M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$207.29M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$149.12M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$388.52M	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$-39.30M	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$-66.54M	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$34.46M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$-1.85M	USD	1 Quarter
Interest expense	`InterestExpense`	$15.10M	USD	2 Qtrs
Interest expense	`InterestExpense`	$7.59M	USD	1 Quarter
Interest expense	`InterestExpense`	$7.94M	USD	1 Quarter
Interest expense	`InterestExpense`	$15.79M	USD	2 Qtrs
Unrealized gain on restricted equity securities	`UnrealizedGainLossOnInvestmentInRestrictedEquitySecurities`	$22.64M	USD	2 Qtrs
Unrealized gain on restricted equity securities	`UnrealizedGainLossOnInvestmentInRestrictedEquitySecurities`	$20.96M	USD	1 Quarter
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$4.61M	USD	1 Quarter
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$9.18M	USD	2 Qtrs
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$6.66M	USD	2 Qtrs
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$3.53M	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$16.03M	USD	2 Qtrs
Total other income (expense), net	`NonoperatingIncomeExpense`	$-4.06M	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$17.63M	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$-8.43M	USD	2 Qtrs
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-50.50M	USD	2 Qtrs
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.91M	USD	1 Quarter
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$52.09M	USD	1 Quarter
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-47.73M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$274.00K	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$753.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-5.91M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-102.11M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-50.78M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$51.34M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-41.82M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-47.73M	USD	2 Qtrs
Unrealized gain (loss) on available-for-sale debt securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-959.00K	USD	2 Qtrs
Unrealized gain (loss) on available-for-sale debt securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$888.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale debt securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$2.58M	USD	2 Qtrs
Unrealized gain (loss) on available-for-sale debt securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$878.00K	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-48.69M	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-5.03M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$52.22M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-48.20M	USD	2 Qtrs
Net income (loss) per share, basic	`EarningsPerShareBasic`	$-0.53	USD	2 Qtrs
Net income (loss) per share, basic	`EarningsPerShareBasic`	$-0.56	USD	2 Qtrs
Net income (loss) per share, basic	`EarningsPerShareBasic`	$-0.07	USD	1 Quarter
Net income (loss) per share, basic	`EarningsPerShareBasic`	$0.56	USD	1 Quarter
Net income (loss) per share, diluted	`EarningsPerShareDiluted`	$-0.56	USD	2 Qtrs
Net income (loss) per share, diluted	`EarningsPerShareDiluted`	$-0.53	USD	2 Qtrs
Net income (loss) per share, diluted	`EarningsPerShareDiluted`	$-0.07	USD	1 Quarter
Net income (loss) per share, diluted	`EarningsPerShareDiluted`	$0.54	USD	1 Quarter
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	90.10M	shares	1 Quarter
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	91.23M	shares	2 Qtrs
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	91.39M	shares	1 Quarter
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	89.81M	shares	2 Qtrs
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	91.23M	shares	2 Qtrs
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	89.81M	shares	2 Qtrs
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	94.78M	shares	1 Quarter
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	90.10M	shares	1 Quarter

Cash Flow Statement 57 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-47.73M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-50.78M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$31.73M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$33.70M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.67M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$3.35M	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$9.28M	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$8.61M	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$687.00K	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$655.00K	USD	2 Qtrs
(Accretion) amortization of discounts/premiums on investments, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$832.00K	USD	2 Qtrs
(Accretion) amortization of discounts/premiums on investments, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.06M	USD	2 Qtrs
Change in fair value of restricted equity securities	`ChangeInFairValueOfRestrictedInvestmentInEquitySecurities`	$22.64M	USD	2 Qtrs
Other	`OtherOperatingActivitiesCashFlowStatement`	$-420.00K	USD	2 Qtrs
Other	`OtherOperatingActivitiesCashFlowStatement`	$116.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$39.12M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$11.52M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$3.27M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$1.15M	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-18.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$2.89M	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$4.27M	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$7.74M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-175.00K	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$11.31M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-18.01M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-48.33M	USD	2 Qtrs
Purchases of available-for-sale debt securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$224.08M	USD	2 Qtrs
Purchases of available-for-sale debt securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$235.90M	USD	2 Qtrs
Sales and maturities of available-for-sale debt securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$339.74M	USD	2 Qtrs
Sales and maturities of available-for-sale debt securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$138.93M	USD	2 Qtrs
Purchase of restricted equity securities	`PaymentsToAcquireRestrictedInvestments`	$54.72M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.39M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$6.44M	USD	2 Qtrs
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$30.00K	USD	2 Qtrs
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$4.00K	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$40.73M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-91.56M	USD	2 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$6.87M	USD	2 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$22.26M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.87M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$22.26M	USD	2 Qtrs
Change in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-87.31M	USD	2 Qtrs
Change in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-729.00K	USD	2 Qtrs
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$259.21M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$146.46M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$147.19M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$171.90M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$259.21M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$146.46M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$147.19M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$171.90M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$5.82M	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$5.82M	USD	2 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	$425.00K	USD	2 Qtrs
Non-cash capital expenditures	`CapitalExpendituresIncurredButNotYetPaid`	$3.24M	USD	2 Qtrs
Non-cash capital expenditures	`CapitalExpendituresIncurredButNotYetPaid`	$911.00K	USD	2 Qtrs

Stockholders Equity 31 line items

Line Item	Tag	Value	Unit	Period
Begining balance	`StockholdersEquity`	$409.27M	USD	Point-in-time
Begining balance	`StockholdersEquity`	$372.14M	USD	Point-in-time
Begining balance	`StockholdersEquity`	$364.49M	USD	Point-in-time
Begining balance	`StockholdersEquity`	$483.71M	USD	Point-in-time
Begining balance	`StockholdersEquity`	$480.76M	USD	Point-in-time
Begining balance	`StockholdersEquity`	$377.44M	USD	Point-in-time
Net income (loss)	`NetIncomeLoss`	$-5.91M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-102.11M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-50.78M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$51.34M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-41.82M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-47.73M	USD	2 Qtrs
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$888.00K	USD	1 Quarter
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.70M	USD	1 Quarter
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$878.00K	USD	1 Quarter
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.85M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$17.93M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.85M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$19.88M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$15.76M	USD	1 Quarter
Issuance of common stock for stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.58M	USD	1 Quarter
Issuance of common stock for stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$4.28M	USD	1 Quarter
Issuance of common stock for stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$16.14M	USD	1 Quarter
Issuance of common stock for stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.12M	USD	1 Quarter
Issuance of common stock for employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$2.54M	USD	1 Quarter
Ending balance	`StockholdersEquity`	$409.27M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$372.14M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$364.49M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$483.71M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$480.76M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$377.44M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.